2017
DOI: 10.18632/oncotarget.19028
|View full text |Cite
|
Sign up to set email alerts
|

Flexible ligated ruthenium(II) self-assemblies sensitizes glioma tumor initiating cells in vitro

Abstract: The tumorigenic potentials of residual cancer stem-like cells within tumors represent limitations of current cancer therapies. Here, the authors describe the effects of synthesized flexible, ligated, supramolecular self-assembled chair type tetranuclear ruthenium (II) metallacycles (2–5) on glioblastoma and glioma stem like cells. These self-assemblies were observed to be selectively toxic to glioma cells and CD133-positive glioma stem like cells population. Of the self-assembled compounds tested, metallacycle… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 57 publications
(51 reference statements)
0
4
0
Order By: Relevance
“…Different proteins interacting with such metalla-assemblies have been identified. Interestingly, these studies have shown that metalla-assemblies of different shapes, sizes, structures and numbers of charges are able to interact with proteins, confirming that interaction with biomolecules is a common feature of arene ruthenium metalla-assemblies (Dubey et al, 2015; Elumalai et al, 2016, 2017).…”
Section: Protein Interactionsmentioning
confidence: 80%
“…Different proteins interacting with such metalla-assemblies have been identified. Interestingly, these studies have shown that metalla-assemblies of different shapes, sizes, structures and numbers of charges are able to interact with proteins, confirming that interaction with biomolecules is a common feature of arene ruthenium metalla-assemblies (Dubey et al, 2015; Elumalai et al, 2016, 2017).…”
Section: Protein Interactionsmentioning
confidence: 80%
“…Previously, Elumalai et al [ 30 ] reported a Ru(II) metallacycle that can eliminate glioma CSCs. The Ru(II) triazine complex has been reported to have the capacity to eradicate colorectal and breast CSCs [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…In this work, we report for the first time that two Ru(II) complexes, 1 and 2, suppress liver CSCs by targeting NF-κB and Akt/mTOR signaling. Previously, Elumalai et al [30] reported a Ru(II) metallacycle that can eliminate glioma CSCs. The Ru(II) triazine complex has been reported to have the capacity to eradicate colorectal and breast CSCs [31].…”
Section: Discussionmentioning
confidence: 99%
“…In addition to the works mentioned above, there are other research studies on Ru 2+ ‐coordinated metallabowls, [ 141 ] metallacycles, [ 142 ] and metallogel. [ 80 ] Overall, because of the intrinsic anticancer capability of Ru 2+ , Ru 2+ ‐coordinated intelligent nanomedicine will attract more attention for the development of new cancer theranostic agents in the near future.…”
Section: Metal‐coordinated Supramolecular Self‐assemblies For Cancer ...mentioning
confidence: 99%